– REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. NCT04425629.
– SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. NCT04427501.
– Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine. NCT04436276.
– Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. NCT04338360.
– Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. NCT04470427.
Covid-19: resultados de ensayos clínicos
En la sección: Actualidades, COVID-19, Infectología, Vacunología. Publicado en: . 
Haga un comentario